Diagnosis and Treatment of Late Neurological Ischemic Deficit in Adults with Aneurysmal Subarachnoid Hemorrhage
Led by Fondazione IRCCS San Gerardo dei Tintori · Updated on 2025-02-03
1400
Participants Needed
33
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research investigates patients who have experienced aneurysmal subarachnoid hemorrhage aSAH, a type of stroke caused by bleeding from a ruptured brain aneurysm. The study focuses on a complication called delayed ischemic neurological deficit DIND, which can lead to delayed cerebral ischemia and poor neurological outcomes despite early treatment. Researchers aim to understand how often DIND occurs, how it is diagnosed, and the treatments used across different centers, as well as the impact on patients recovery both short- and long-term.
Participants include those diagnosed with aSAH, confirmed by imaging tests, who are admitted to intensive care. The study collects data on neurological symptoms and imaging to identify DIND and monitors instrumental methods like continuous EEG and ultrasound for diagnosis, especially in patients unable to be examined clinically. Researchers also observe various treatment approaches such as blood pressure management, local drug infusions, and mechanical interventions like angioplasty to compare their use and outcomes.
During participation, patients undergo neurological examinations and imaging tests including CT and MRI to assess brain function and injury. Instrumental monitoring of intracranial pressure and cerebral blood flow is recorded to support diagnosis and management. The study follows patients for 12 months to measure the incidence of DIND and evaluate neurological and functional outcomes over time. Data on treatment intensity and monitoring usefulness are also collected to improve understanding of managing this condition.
CONDITIONS
Brief Title
Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.
Research Team
G
Giuseppe Citerio, Professor, Head of Department
C
Clinical Research Coordination Office
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Primary diagnosis of subarachnoid hemorrhage due to rupture of a cerebral artery aneurysm confirmed by cerebral angiotomography or angiography
Need for admission to the Intensive Care Unit
Signed informed consent form to participate in the study according to local regulations
You will not qualify if you...
Age under 18 years
Subarachnoid hemorrhage caused by trauma, arteriovenous malformation, or brain tumor bleeding (non-aneurysmal causes)
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Up to 12 months
Participants undergo clinical neurological examinations and instrumental monitoring such as continuous EEG and transcranial Doppler ultrasound to identify delayed ischemic neurological deficit (DIND) and cerebral vasospasm.
Repeated imaging and monitoring visits depending on clinical status
Long-term Monitoring
Duration - Up to 12 months
Participants are observed over time to assess neurological-functional outcomes and the incidence of delayed ischemic neurological deficit following subarachnoid hemorrhage.
Follow-up visits as scheduled for outcome assessment
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group.
Mervyn D I Vergouwen, Marinus Vermeulen, Jan van Gijn...
Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017.
Rita V Krishnamurthi, Takayoshi Ikeda, Valery L Feigin
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.
Brian L Hoh, Nerissa U Ko, Sepideh Amin-Hanjani...